Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 176,757,840
  • Shares Outstanding, K 3,098,840
  • Annual Sales, $ 37,417 M
  • Annual Income, $ 112,000 K
  • 60-Month Beta 0.49
  • Price/Sales 4.60
  • Price/Cash Flow 12.23
  • Price/Book 4.79
Trade AZN with:

Options Overview Details

View History
  • Implied Volatility 30.50% ( +1.99%)
  • Historical Volatility 27.79%
  • IV Percentile 85%
  • IV Rank 65.20%
  • IV High 35.62% on 11/08/21
  • IV Low 20.91% on 12/27/21
  • Put/Call Vol Ratio 0.43
  • Today's Volume 3,398
  • Volume Avg (30-Day) 6,547
  • Put/Call OI Ratio 1.10
  • Today's Open Interest 167,410
  • Open Int (30-Day) 154,867

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.75
  • Number of Estimates 4
  • High Estimate 0.80
  • Low Estimate 0.71
  • Prior Year 0.54
  • Growth Rate Est. (year over year) +38.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.65 +6.50%
on 09/26/22
62.18 -9.83%
on 09/12/22
-4.62 (-7.61%)
since 09/02/22
3-Month
52.65 +6.50%
on 09/26/22
68.39 -18.01%
on 07/19/22
-9.44 (-14.41%)
since 07/05/22
52-Week
52.65 +6.50%
on 09/26/22
71.70 -21.80%
on 04/08/22
-3.82 (-6.38%)
since 10/05/21

Most Recent Stories

More News
Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks

Reata Pharmaceuticals (RETA) is yet to generate product revenues due to the lack of marketed drugs in its portfolio. However, two of its pipeline candidates are close to potential FDA approval.

AZN : 56.29 (-1.31%)
ABBV : 142.04 (+0.04%)
RETA : 25.06 (-1.80%)
Is Illumina Still the Gamechanger in Genomics Sequencing?

Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused

ILMN : 207.12 (+1.00%)
NTRA : 45.80 (-4.40%)
EXAS : 35.15 (-2.79%)
MYGN : 20.48 (-0.63%)
AZN : 56.29 (-1.31%)
Astrazeneca (AZN) Gains But Lags Market: What You Should Know

Astrazeneca (AZN) closed at $55.55 in the latest trading session, marking a +1.29% move from the prior day.

AZN : 56.29 (-1.31%)
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine

Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive agreement to acquire Lexington, Mass.-based LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine...

AZN : 56.29 (-1.31%)
LOGC : 2.03 (+0.50%)
Zacks.com featured highlights include Coca-Cola, General Dynamics, AstraZeneca, Boise Cascade and Insperity

Coca-Cola, General Dynamics, AstraZeneca, Boise Cascade and Insperity have been highlighted in this Screen of The Week article.

GD : 226.15 (-0.22%)
AZN : 56.29 (-1.31%)
KO : 55.80 (-1.73%)
NSP : 106.88 (-1.67%)
BCC : 62.76 (-1.24%)
What This News Means for Merck

Cancer drug Lynparza received an approval in China to treat patients with a type of ovarian cancer.

RHHBY : 41.6200 (-1.91%)
MRK : 88.38 (-0.01%)
AZN : 56.29 (-1.31%)
5 Dividend Growth Stocks to Beat Market Volatility

Coca-Cola (KO), General Dynamics (GD), AstraZeneca (AZN), Boise Cascade (BCC), and Insperity (NSP) that offer dividend growth could be compelling picks amid market volatility.

GD : 226.15 (-0.22%)
AZN : 56.29 (-1.31%)
KO : 55.80 (-1.73%)
NSP : 106.88 (-1.67%)
BCC : 62.76 (-1.24%)
AZN vs. LLY: Which Stock Is the Better Value Option?

AZN vs. LLY: Which Stock Is the Better Value Option?

AZN : 56.29 (-1.31%)
LLY : 328.53 (-0.41%)
Adding $100 to These 7 Stocks Would Be a Genius Move Right Now

You don't need a mountain of cash to build wealth on Wall Street -- especially with deals like these.

COMP : 2.50 (-4.94%)
DIS : 99.21 (-2.20%)
AZN : 56.29 (-1.31%)
EPD : 24.76 (-0.12%)
FVRR : 31.42 (-3.83%)
USB : 42.12 (-1.20%)
NEE : 81.20 (-1.96%)
PINS : 23.95 (-3.82%)
Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why

Valneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance purchase agreement jeopardizes its COVID-19 vaccine program.

AZN : 56.29 (-1.31%)
PFE : 43.81 (-1.46%)
MORF : 27.89 (-3.63%)
VALN : 10.88 (-7.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 58.39
2nd Resistance Point 57.75
1st Resistance Point 57.40
Last Price 56.29
1st Support Level 56.40
2nd Support Level 55.76
3rd Support Level 55.41

See More

52-Week High 71.70
Fibonacci 61.8% 64.42
Fibonacci 50% 62.17
Fibonacci 38.2% 59.93
Last Price 56.29
52-Week Low 52.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar